Hormone/Antihormone Withdrawal and Dexamethasone for Hormone-Refractory Prostate Cancer
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.1998.tb00233.x/fullpdf
Reference19 articles.
1. A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
2. Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal Syndrome
3. Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
4. Prostate-specific antigen decline after casodex withdrawal: Evidence for an antiandrogen withdrawal syndrome
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy;Nature Reviews Urology;2015-12-08
2. Low-Dose Docetaxel Combined with Dexamethasone Is Feasible for Patients with Castration-Resistant Prostate Cancer;Chemotherapy;2015-11-04
3. An open-label, phase 2 trial of bicalutamide dose escalation from 50 mg to 150 mg in men with CAB and castration resistance. A Canadian Urology Research Consortium Study;Prostate Cancer and Prostatic Diseases;2014-09-02
4. Oral low-dose dexamethasone for androgen-independent prostate cancer patients;Oncology Letters;2010-01
5. Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2007-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3